Interview

As 2026 approaches, the clinical trials landscape is evolving rapidly—driven by innovative technologies, shifting patient needs, and a strong push for global inclusion. In this exclusive interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how clinical trial supply chains are being reshaped by new challenges and opportunities. From the rise of AI and automation to the shift towards decentralised, patient-centric trials, Steve offers valuable insights on how the industry can not only adapt but thrive.

Discover how embracing cutting-edge technology, reinforcing data integrity, and championing sustainability will future-proof clinical operations in a complex, diverse world.

Download the interview to learn more about:

• AI & Automation: Revolutionising trials by speeding up development, boosting efficiency, and enhancing data quality.
• Decentralisation & Patient-Centric Models: Elevating trial operations through improved enrolment and retention.
• Sustainability & Global Inclusion: Integrating greener practices while ensuring accessibility for diverse populations.

The clinical trial supply chain is undergoing a radical transformation. With the complexity of multi-indication treatments and rare disease trials driving new challenges, innovative technologies and strategies are now essential. As we head into 2026, these pressures are intensifying, making advanced solutions more critical than ever. In this interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how advanced tools and patient-centric approaches are reshaping every link in the supply chain.

Download this interview to learn more about:

• Transforming Clinical Supply Chains: AI and automation streamline data collection, enhance forecasting accuracy, and reduce manual inefficiencies to ensure timely supplies and improved operational performance.
• Decentralised Trials & Direct-to-Patient Models: Direct-to-patient approaches address recruitment challenges and complex multi-indication studies, elevating enrolment, retention, and overall supply chain effectiveness.
• Integrated Systems & Sustainability: Scalable, eco-friendly systems overcome packaging, regulatory, and drug return challenges while ensuring global access and robust data integrity.